These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 25684038)

  • 1. The Association of Serum Galectin-3 Levels with Atrial Electrical and Structural Remodeling.
    Yalcin MU; Gurses KM; Kocyigit D; Canpinar H; Canpolat U; Evranos B; Yorgun H; Sahiner ML; Kaya EB; Hazirolan T; Tokgozoglu L; Oto MA; Ozer N; Guc D; Aytemir K
    J Cardiovasc Electrophysiol; 2015 Jun; 26(6):635-40. PubMed ID: 25684038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of persistent atrial fibrillation on serum galectin-3 levels.
    Gurses KM; Yalcin MU; Kocyigit D; Canpinar H; Evranos B; Yorgun H; Sahiner ML; Kaya EB; Ozer N; Tokgozoglu L; Oto MA; Guc D; Aytemir K
    Am J Cardiol; 2015 Mar; 115(5):647-51. PubMed ID: 25604929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. M2-muscarinic acetylcholine receptor autoantibody levels predict left atrial fibrosis severity in paroxysmal lone atrial fibrillation patients undergoing cryoablation.
    Gurses KM; Yalcin MU; Kocyigit D; Kesikli SA; Canpolat U; Yorgun H; Sahiner ML; Kaya EB; Hazirolan T; Ozer N; Oto MA; Guc D; Aytemir K
    Europace; 2015 Feb; 17(2):239-46. PubMed ID: 25238749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between vitamin D level and left atrial fibrosis in patients with lone paroxysmal atrial fibrillation undergoing cryoballoon-based catheter ablation.
    Canpolat U; Aytemir K; Hazirolan T; Özer N; Oto A
    J Cardiol; 2017 Jan; 69(1):16-23. PubMed ID: 27554047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective DE-MRI study evaluating the role of TGF-β1 in left atrial fibrosis and implications for outcomes of cryoballoon-based catheter ablation: new insights into primary fibrotic atriocardiomyopathy.
    Canpolat U; Oto A; Hazirolan T; Sunman H; Yorgun H; Şahiner L; Kaya EB; Aytemir K
    J Cardiovasc Electrophysiol; 2015 Mar; 26(3):251-9. PubMed ID: 25366936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum YKL-40 as a Marker of Left Atrial Fibrosis Assessed by Delayed Enhancement MRI in Lone Atrial Fibrillation.
    Canpolat U; Aytemir K; Hazirolan T; Özer N; Oto A
    Pacing Clin Electrophysiol; 2015 Dec; 38(12):1386-95. PubMed ID: 26256257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of cryoballoon-based catheter ablation on left atrial structural and potential electrical remodeling in patients with paroxysmal atrial fibrillation.
    Canpolat U; Aytemir K; Özer N; Oto A
    J Interv Card Electrophysiol; 2015 Nov; 44(2):131-9. PubMed ID: 26238480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The degree of left atrial structural remodeling impacts left ventricular ejection fraction in patients with atrial fibrillation.
    Akkaya M; Marrouche N; Higuchi K; Koopmann M; Damal K; Kholmovski E; McGann C
    Turk Kardiyol Dern Ars; 2014 Jan; 42(1):11-9. PubMed ID: 24481089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-3: A biochemical marker to detect paroxysmal atrial fibrillation?
    Selcoki Y; Aydin Hİ; Celik TH; Isleyen A; Erayman A; Demircelik MB; Demirin H; Kosus A; Eryonucu B
    Clin Invest Med; 2016 Dec; 39(6):27528. PubMed ID: 27917818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-cardiac and peripheral levels of biochemical markers of fibrosis in patients undergoing catheter ablation for atrial fibrillation.
    Begg GA; Karim R; Oesterlein T; Graham LN; Hogarth AJ; Page SP; Pepper CB; Rhode K; Lip GYH; Holden AV; Plein S; Tayebjee MH
    Europace; 2017 Dec; 19(12):1944-1950. PubMed ID: 28339804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age, atrial fibrillation, and structural heart disease are the main determinants of left atrial fibrosis detected by delayed-enhanced magnetic resonance imaging in a general cardiology population.
    Cochet H; Mouries A; Nivet H; Sacher F; Derval N; Denis A; Merle M; Relan J; Hocini M; Haïssaguerre M; Laurent F; Montaudon M; Jaïs P
    J Cardiovasc Electrophysiol; 2015 May; 26(5):484-92. PubMed ID: 25727248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of left atrial function and left atrial enhancement in patients with atrial fibrillation: cardiac magnetic resonance study.
    Habibi M; Lima JA; Khurram IM; Zimmerman SL; Zipunnikov V; Fukumoto K; Spragg D; Ashikaga H; Rickard J; Marine JE; Calkins H; Nazarian S
    Circ Cardiovasc Imaging; 2015 Feb; 8(2):e002769. PubMed ID: 25652181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The change in circulating galectin-3 predicts absence of atrial fibrillation after thoracoscopic surgical ablation.
    Berger WR; Jagu B; van den Berg NWE; Chan Pin Yin DRPP; van Straalen JP; de Boer OJ; Driessen AHG; Neefs J; Krul SPJ; van Boven WP; van der Wal AC; de Groot JR
    Europace; 2018 May; 20(5):764-771. PubMed ID: 28525549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between AF substrate ablation difficulty and left atrial fibrosis quantified by delayed-enhancement cardiac magnetic resonance.
    Seitz J; Horvilleur J; Lacotte J; O H-Ici D; Mouhoub Y; Maltret A; Salerno F; Mylotte D; Monchi M; Garot J
    Pacing Clin Electrophysiol; 2011 Oct; 34(10):1267-77. PubMed ID: 21651593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the Correlation of Galectin-3 Concentration with the Measurements of Echocardiographic Parameters Assessing Left Atrial Remodeling and Function in Patients with Persistent Atrial Fibrillation.
    Wałek P; Grabowska U; Cieśla E; Sielski J; Roskal-Wałek J; Wożakowska-Kapłon B
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galectin-3 in Atrial Fibrillation: Mechanisms and Therapeutic Implications.
    Clementy N; Piver E; Bisson A; Andre C; Bernard A; Pierre B; Fauchier L; Babuty D
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29587379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study.
    Marrouche NF; Wilber D; Hindricks G; Jais P; Akoum N; Marchlinski F; Kholmovski E; Burgon N; Hu N; Mont L; Deneke T; Duytschaever M; Neumann T; Mansour M; Mahnkopf C; Herweg B; Daoud E; Wissner E; Bansmann P; Brachmann J
    JAMA; 2014 Feb; 311(5):498-506. PubMed ID: 24496537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of Late Gadolinium Enhancement - Magnetic Resonance Imaging in the Measurement of Left Atrial Substrate Remodeling in Patients With Rheumatic Mitral Valve Disease and Persistent Atrial Fibrillation.
    Zhu D; Wu Z; van der Geest RJ; Luo Y; Sun J; Jiang J; Chen Y
    Int Heart J; 2015; 56(5):505-10. PubMed ID: 26370371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of the Atrial Electromechanical Delay in Predicting Atrial Fibrillation in Myotonic Dystrophy Type 1 Patients.
    Russo V; Rago A; Ciardiello C; Russo MG; Calabrò P; Politano L; Nigro G
    J Cardiovasc Electrophysiol; 2016 Jan; 27(1):65-72. PubMed ID: 26331589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Association of plasma fibronectin level with left atrial electrical and structural remodelling in lone paroxysmal atrial fibrillation: a cross-sectional study].
    Canpolat U; Oto A; Yorgun H; Sunman H; Şahiner L; Kaya EB; Özer N; Aytemir K
    Turk Kardiyol Dern Ars; 2015 Apr; 43(3):259-68. PubMed ID: 25905997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.